Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 9:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 3,925 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: HTN Clear all

Conditions: Hypertension, Vitamin D Deficiency, Pre-Hypertension
Interventions: Cholecalciferol; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 50 Years
Enrollment: 534 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 3
States / cities: Hartford, Connecticut • Boston, Massachusetts • Minneapolis, Minnesota

Conditions: Hypertension, Diabete Type 2
Interventions: Treatment as Usual Plus Occupational Therapy, Treatment as Usual; Behavioral
Lead sponsor: University of Indianapolis; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Hypertension
Interventions: Home Blood Pressure Monitoring; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 85 Years
Enrollment: 348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Interstitial Lung Disease
Interventions: alternative six minute walk test, Standard six minute walk test; Procedure
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years to 90 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Falls Church, Virginia

Conditions: Hypertension
Interventions: Aliskiren, Amlodipine, Hydrochlorothiazide; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 556 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Santa Fe, New Mexico

Conditions: Pre-Hypertension
Interventions: Lifestyle modification; Behavioral
Lead sponsor: Florida Heart Research Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Not listed
Lead sponsor: VeraLight, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Hyattsville, Maryland

Conditions: Physical Activity
Interventions: HeartSteps: A just-in-time intervention for increasing physical activity among sedentary adults.; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 75 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hypertension, Prehypertension, Overweight, Obesity, Hypertrophy, Left Ventricular
Interventions: Electronic Media Application, Standard of care education; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 13 Years to 22 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypertension, Diabetes, Dyslipidemia
Interventions: Medication Adherence Smartphone App; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 3
States / cities: Little Rock, Arkansas

Conditions: Pulmonary; Hypertension, Steatosis, Right Ventricular Failure
Interventions: Omega-3 fatty acids; Dietary Supplement
Lead sponsor: Wen-Chih Wu; Federal
Eligibility: 30 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Glaucoma Open-Angle Primary, Ocular Hypertension
Interventions: H-1337 0.6%, H-1337 1.0%, H-1337 Placebo, Timolol 0.5%; Drug
Lead sponsor: D. Western Therapeutics Institute, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 9
States / cities: Glendale, California • Colorado Springs, Colorado • Lakeland, Florida + 6 more

Conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases
Interventions: 25 g of Freeze-dried Strawberry Powder, 50 g of Freeze-dried Strawberry Powder, Placebo Powder; Dietary Supplement
Lead sponsor: Florida State University; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Upper Respiratory Infection, Hypertension, Diabetes
Interventions: Spanish speaker level; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Fresno, California

Conditions: Cardiovascular Diseases, Hypertension, Diet
Interventions: Energy Drink, Water Control; Dietary Supplement · Other
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years to 30 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Glaucoma, Ocular Hypertension
Interventions: bimatoprost eye drops, placebo; Drug
Lead sponsor: Allergan; Industry
Eligibility: 18 Years and older
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Hypertension,Essential
Interventions: Captopril Pill, Enalapril Pill, Hydrochlorothiazide; Drug
Lead sponsor: Penn State University; Other
Eligibility: 40 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Pulmonary Arterial Hypertension
Interventions: Nitric Oxide; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Hypertension, Stroke
Interventions: Informational Guide for Patients, Video-Assisted Coaching, Monograph for Physicians, Educational Coaching, Control; Other · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 99 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Ocular Hypertension, Open Angle Glaucoma
Interventions: AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic Solution 0.02%, AR-13324 Ophthalmic Solution 0.04%, AR-13324 Ophthalmic Solution Vehicle; Drug · Other
Lead sponsor: Aerie Pharmaceuticals; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 11
States / cities: Newport Beach, California • Fairfield, Connecticut • Roswell, Georgia + 8 more

Conditions: Cardiovascular Diseases, Hypertension, Diabetes Type 2, Stroke, Recruitment, Overweight and Obesity, Hyperlipidemias
Interventions: EHR-informed Recruitment Method of Contact, Educational Text-Messages and Connection to Cardiovascular Research Opportunities; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pregnancy Induced Hypertension, Preeclampsia and Eclampsia, Gestational Hypertension
Interventions: L-citrulline, Placebo; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Hypertension, Insulin Resistance, Dyslipidemia
Interventions: Telmisartan; Drug
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Stanford, California

Conditions: Hypertension
Interventions: BP Track; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

DAYLIGHT: Vitamin D Therapy in Individuals at High Risk of Hypertension

Effect of Occupational Therapy in Promoting Medication Adherence

Home Blood Pressure Monitoring Project

The Six Minute Walk Test: Influence of Instruction on Results

An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure

Study of Hispanics to Assess Risk Prevention in Prehypertension

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

An mHealth Mobile Application Supporting Maintenance of Physical Activity Among Men and Women With High Blood Pressure

EMPower: Electronic Media Powering Positive Health Changes in Youth

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Reversal of Right Ventricular Steatosis in Pulmonary Hypertension

Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

The Effects of Strawberries on Blood Pressure in Postmenopausal Women

Doctor-Patient Communication in Spanish

The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism

A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans

Nitric Oxide, GeNO Nitrosyl Delivery System

Controlling Hypertension Outcomes by Improved Communication & Engagement

Study of AR-13324 in Patients With Elevated Intraocular Pressure

Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)

Role of L-citrulline in Prevention of Pregnancy Associated Hypertension

Treatment of Insulin Resistance in Hypertensive, Obese Adolescents

Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care